Listed

IGC Pharma, Inc.: Form 10-Q for the period ended Jun 30, 2013

Filed with the SEC on Aug 16, 2013 and accepted by EDGAR at Aug 16, 2013, 17:25 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-04-01 to 2013-06-30$1.1mus-gaap:Revenues
Cost of revenue3 months2013-04-01 to 2013-06-30$936.2kus-gaap:CostOfRevenue
Selling, general and administrative3 months2013-04-01 to 2013-06-30$299.1kus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2013-04-01 to 2013-06-30−$260.8kus-gaap:OperatingIncomeLoss
Interest expense3 months2013-04-01 to 2013-06-30$112.1kus-gaap:InterestExpense
Income tax3 months2013-04-01 to 2013-06-30$1.6kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-04-01 to 2013-06-30−$633.5kus-gaap:NetIncomeLoss
Diluted EPS3 months2013-04-01 to 2013-06-30−$0.09us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-04-01 to 2013-06-30−$0.09us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-04-01 to 2013-06-307,003,023 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2013-04-01 to 2013-06-30−$243.6kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2013-06-30$651.5kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-06-30$3.7mus-gaap:AssetsCurrent
Total assetsAt period end2013-06-30$18.6mus-gaap:Assets
Current liabilitiesAt period end2013-06-30$1.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-06-30$4.1mus-gaap:Liabilities
Shareholders' equityAt period end2013-06-30$13.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001185185-13-001853. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.